Eli Lilly, Abbott and AstraZeneca have run into problems with side effects in developing nicotinic receptor drugs.

FORBES: Magazine Article

Memory Pharmaceuticals has a nicotinic receptor drug for Alzheimer's in midstage trials that is probably a year behind Targacept, figures Lazard Capital Markets analyst Terence Flynn.

FORBES: Magazine Article

Eli Lilly (nyse: LLY - news - people ), Abbott and AstraZeneca have run into problems with side effects in developing nicotinic receptor drugs.

FORBES: The Nicotine Cure

In the late 1800s English physiologist John Langley discovered the muscular nicotinic receptor when he tied a frog muscle to a round drum, put nicotine on the muscle and saw it contract.

FORBES: The Nicotine Cure

Targacept's pill is more refined, he says, because it binds with a subtype of neuronal nicotinic receptor situated mostly in parts of the brain that process sensory information and aid in learning and short-term memory.

FORBES: The Nicotine Cure

Memory Pharmaceuticals (nasdaq: MEMY - news - people ) has a nicotinic receptor drug for Alzheimer's in midstage trials that is probably a year behind Targacept, figures Lazard (nyse: LAZ - news - people ) Capital Markets analyst Terence Flynn.

FORBES: The Nicotine Cure